#JNJ hashtag - Bluesky

5 days ago

On this day in 1991, Jack & Jennifer find themselves stranded in a cave.

#DAYS #DOOL #JnJ

0 1 0 0

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis Johnson& Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies. Nearly 60% of adolescents treated with ICOTYDE achieved completely clear skin at Week 52 in the ICONIC-LEAD study. SPRING HOUSE, Pa., March 28, 2026/ PRNewswire/-- Johnson& Johnson today announced new long-term 52- week...

6 days ago

#JNJ ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

www.stocktitan.net/news/JNJ/icotydetm-icotr...

0 0 0 0

TrendSpider

@trendspider.com

1 week ago

Rinse and repeat? #JNJ

1 0 0 0

1 week ago

On this day in 1990, Jack & Jennifer wonder what it would be like to have a son.

#DAYS #DOOL #JnJ

1 2 0 0

@jorgemberryklmela.bsky.social

1 week ago

On this day in 2012, Abby admits she lied about sleeping with Austin.

#DAYS #DOOL #Abby #Caustin #JnJ

3 1 0 0

Charlotte Davis

1 week ago

💰 Dividend yield of around 2.8%, offering solid defensive appeal in uncertain markets.

📊 Analysts are optimistic about the healthcare sector’s resilience, with JNJ well-positioned as a safe-haven play. Target sits at US$290+.

#Healthcare #JNJ #DefensiveStocks #Investing #Dividends #MarketOutlook

2 0 0 0

FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide Johnson & Johnson (NYSE: JNJ) announced FDA approval of ICOTYDE (icotrokinra) on March 18, 2026, for moderate-to-severe plaque psoriasis in adults and adolescents 12+ who weigh ≥40 kg.ICOTYDE is the first oral IL‑23 receptor peptide; Phase 3 data (2,500 patients) showed ~70% IGA 0/1 and 55% PASI 90 at Week 16 with adverse reaction rates within 1.1% of placebo through Week 16 and no new safety signals through Week 52.

2 weeks ago

#JNJ FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

www.stocktitan.net/news/JNJ/fda-approval-of...

0 0 0 0

@pharmalot.bsky.social

2 weeks ago

Pharmalittle: We're reading about obesity pill trial results, cholesterol guidelines, and more Structure Therapeutics disclosed that its daily obesity pill led patients to lose about 16% of their body weight relative to placebo after 44 weeks

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about obesity pill trial results, cholesterol guidelines, and more news.. statnews.com/pharmalot/20... #pharma #obesity #cholesterol #RSV #vaccines #GSK #JNJ #CVS

0 0 0 0

2 weeks ago

Happy Birthday to Melissa Reeves!

#DAYS #DOOL #Jennifer #JnJ

0 1 0 0

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer Johnson & Johnson (NYSE:JNJ) presented Phase 1 Erda-iDRS data at EAU 2026 showing an 89% complete response rate in intermediate-risk non–muscle-invasive bladder cancer with a median complete-response duration of 18 months (95% CI, 14–25). Median recurrence-free survival in high-risk patients was 20 months.Treatment met its primary safety endpoint, showed predominantly local adverse events, limited systemic exposure, and supports ongoing Phase 2 and Phase 3 MoonRISe studies.

3 weeks ago

#JNJ Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

www.stocktitan.net/news/JNJ/johnson-johnson...

0 0 0 0

New J&J cataract lens wins FDA approval, 97% report no very bothersome glare First FDA‑approved EDOF lens keeping contrast sensitivity at monofocal levels gives U.S. cataract patients a new way to tackle presbyopia and cut glasses use.

3 weeks ago

#JNJ Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

www.stocktitan.net/news/JNJ/johnson-johnson...

0 0 0 0

3 weeks ago

kaia naked with her legs open saying "well? whatre you waiting for?"

just put it in already

#nsfwoc #ocnsfw #jnj #nsfwart #oc

3 0 0 0

4 weeks ago

kaia's naked tits covered in cum

*whistles* damn that's a lot out of you huh cumblaster mcgee

#ocnsfw #nsfwart #oc #jnj #oppai #doodle

4 0 0 0

4 weeks ago

kaia in yellow lingerie 💛

kaia 👀💛

#art #nsfwoc #ocnsfw #jnj

4 0 0 0

4 weeks ago

my oc kaia she has blue hair and pink eyes and big tits c:. the face of a whore who wants to give backshots.

introduce my oc kaia!!

she's a whore, a slut, AND a princess <333

facts about her:
- 24 years old
- 5 feet tall
- professional magic dancer
- fucks all three of her older brothers ❤️

later i promise ill show her being fucked rough and hard <33333

#art #oc #nsfwoc #jnj #incest

3 0 0 0

@yoshitakahoshi.bsky.social

4 weeks ago

kaia is topless and saying "suck a girls dick and take her to taco bell"

posting this separately too

kaia loves sucking dick and there's a girl she has in mind 👀

#oc #ocnsfw #nsfwoc #jnj

2 0 0 0

星良孝 Yoshitaka Hoshi

4 weeks ago

ジョンソン・エンド・ジョンソン、AF SymposiumでAFib領域のPFA・超音波ポートフォリオ更新を発表──VARIPULSE PlusとNUVISION NAV商用展開、11件の抄録発表予定 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Johnson & Johnson MedTech Highlights Latest PFA and Ultrasound Portfolio Advancements for Atrial Fibrillation at AF Symposium

stellanews.life/medicaldevic...

#AFib #MedTech #PFA #Ultrasound #AFSymposium #JNJ #Cardiology #Electrophysiology

0 0 0 0

4 weeks ago

On this day in 2022, Jack & Jennifer are reunited with Abby.

#DAYS #DOOL #JnJ #Abby

0 1 0 0

Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) Johnson & Johnson (NYSE: JNJ) announced that nipocalimab received U.S. FDA Fast Track designation for adults with systemic lupus erythematosus (SLE) on March 3, 2026. The designation recognizes unmet need and may expedite development and review timelines.Nipocalimab showed reduced lupus disease activity and potential steroid-sparing in a Phase 2 study (JASMINE), and Johnson & Johnson is enrolling adults in the Phase 3 GARDENIA study.

1 month ago

#JNJ Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)

www.stocktitan.net/news/JNJ/johnson-johnson...

0 0 0 0

TrendSpider

@trendspider.com

1 month ago

When did #JNJ start selling semiconductors?

3 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

1 month ago

#MIDD #MCD #SBUX #JNJ #HON #TSN #DD #33ba19a6-e536-422d-abab-b5f2e39697e9 #investing #Consumer #Goods

Origin | Interest | Match

0 0 0 0

@follow-the-money.us

1 month ago

Thomas H. Kean Jr - Integrity Index View Thomas H. Kean Jr's political integrity grade, campaign financing, and conflicts of interest.

Rep. Thomas H. Kean Jr (R-NJ) disclosed 4 trades:
Traded: Jan 23 | Disclosed: Feb 19

Sold: $MKL ($15K-$50K), $SYK ($15K-$50K), $MSFT ($1K-$15K), $JNJ ($15K-$50K)

https://integrityindex.us/candidate/thomas-kean

0 0 0 0